Condition
Breast Cancer Stage
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 9 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownScreening For BCRL In Targeted Therapy For Breast CancerNCT05142800 · 2018-12-13
RECRUITINGMulti-Institutional Transgender & Gender-Diverse Breast Cancer StudyNCT06234488 · 2023-12-08
COMPLETEDMetformin Use to Reduce Disparities in Newly Diagnosed Breast CancerNCT04741204 · 2022-09-01
WITHDRAWNThe Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional StudyNCT05463276 · 2022-02-28
COMPLETEDA Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast CancerNCT05190770 · 2021-12-15
COMPLETEDClinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio SystemNCT05022602 · 2021-08-19
COMPLETEDCOVID-19 Pandemic: Effect on Management of Patients With Breast CancerNCT04929964 · 2020-01-01
COMPLETEDPaclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast CancerNCT03959397 · 2019-06-01
UNKNOWNT-DM1 and Palbociclib for Metastatic HER2 Breast CancerNCT03530696 · 2018-12-06
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED6
RECRUITING1
UNKNOWN1
WITHDRAWN1
Phase mix
PHASE23
NA1
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.